Sarissa Capital Management as of June 30, 2025
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 7 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Innoviva (INVA) | 36.6 | $57M | 2.8M | 20.09 | |
| Neurocrine Biosciences (NBIX) | 24.7 | $38M | 303k | 125.69 | |
| Amarin Corp Sponsored Adr (AMRN) | 13.1 | $20M | 1.2M | 16.22 | |
| Cytokinetics Com New (CYTK) | 12.6 | $19M | 588k | 33.04 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 7.4 | $11M | 16M | 0.72 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 5.1 | $7.9M | 96k | 81.86 | |
| Vor Biopharma (VOR) | 0.5 | $823k | 508k | 1.62 |